LUMICELL
Lumicell is specializing in the field of image-guided cancer surgery. The company's technology illuminates cancer cells in the tumor cavity, enabling physicians to take action in real-time to improve patient outcomes. The company's lead product, consisting of a fluorescent optical contrast agent and a handheld illumination device, is currently under clinical investigation in patients undergoing breast cancer surgery. A planned pivotal study aims to evaluate the ability of the technology to reduc... e positive margin rates and reduce repeat surgeries while sparing healthy tissue. Lumicell technology is also being investigated in colorectal cancer, Barrett’s Esophagus, pancreatic cancer, and brain metastases. In clinical studies to date, no cancer has been missed and the safety profile of the optical contrast agent has been demonstrated. Lumicell was founded in 2008 and is based in Newton, MA, USA.
LUMICELL
Industry:
Biotechnology Hardware Health Care Health Diagnostics Medical
Founded:
2008-01-01
Address:
Wellesley, Massachusetts, United States
Country:
United States
Website Url:
http://www.lumicell.com
Total Employee:
11+
Status:
Active
Contact:
617-404-1001
Email Addresses:
[email protected]
Total Funding:
33.96 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics Google Tag Manager Google Universal Analytics Apache Global Site Tag Microsoft Exchange Online Office 365 Mail
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
LaunchCapital
LaunchCapital investment in Series C - Lumicell
BlueIO
BlueIO investment in Series C - Lumicell
National Science Foundation
National Science Foundation investment in Grant - Lumicell
Rivas Capital
Rivas Capital investment in Seed Round - Lumicell
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-13 | Lumicell Appoints Brent Palmisano Chief Commercial Officer, Builds Commercial Team |
Official Site Inspections
http://www.lumicell.com Semrush global rank: 5.54 M Semrush visits lastest month: 1.54 K
- Host name: 96.147.40.45.host.secureserver.net
- IP address: 45.40.147.96
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Lumicell"
Lumicell: Illuminate Breast Cancer in Real-Time
Lumicell is on a mission to transform cancer surgery. Our fluorescence imaging technology is designed to illuminate residual cancer in real-time.See details»
Who We Are - Lumicell Inc
At Lumicell, our mission is to improve the way cancer surgery is performed, starting with breast cancer. Our innovative, fluorescence-guided imaging technology is designed to illuminate …See details»
Lumicell - Crunchbase Company Profile & Funding
Lumicell is specializing in the field of image-guided cancer surgery. The company's technology illuminates cancer cells in the tumor cavity, enabling physicians to take action in real-time to improve patient outcomes.See details»
Lumicell - Org Chart, Teams, Culture & Jobs - The Org
Lumicell is a biotechnology company that develops and markets image-guided cancer surgery solutions. View Lumicell's up-to-date org chart, open roles, and culture details. Find …See details»
Lumicell lights the way to better patient outcomes
Nov 19, 2024 · Lumicell has developed a cost effective, real-time imaging system for eliminating even single residual cancer cells during surgery and will greatly improve patient outcomes. …See details»
Lumicell’s Cutting-Edge Imaging Platform Receives …
NEWTON, Mass., April 18, 2024—Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue detection during surgery, today announced the U.S. Food & …See details»
Lumicell Announces FDA Advisory Committee’s Positive …
NEWTON, Mass., March 06, 2024 -- (BUSINESS WIRE)-- Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer, today announced …See details»
Startup gives surgeons a real-time view of breast cancer during …
Nov 6, 2024 · Lumicell has developed a handheld device and an optical imaging agent that, when combined, allow surgeons to scan the tissue within the surgical cavity to visualize residual …See details»
Lumicell’s Cutting-Edge Imaging Platform Receives Historic FDA …
NEWTON, Mass., April 18, 2024--Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue detection during surgery,...See details»
Careers at Lumicell - Lumicell Inc
Learn more about careers at Lumicell and apply now. Seeking experience in life sciences, quality, research and development, and more.See details»
Lumicell - VentureRadar
Website: http://lumicell.com/ Develops innovative fluorescence-guided technologies for real-time cancer surgery, including an optical imaging agent, handheld device, and tumor detection …See details»
FDA Reviews Lumicell's Optical Imaging Agent for Breast Cancer
May 22, 2023 · Lumicell, a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced the U.S. Food and Drug …See details»
FDA panel backs Lumicell’s agent for breast cancer imaging tool
Mar 11, 2024 · Lumicell developed the tool to support the detection of cancerous tissue in the resection cavity after the primary specimen is taken out in lumpectomy surgery. Incomplete …See details»
News & Investors - Lumicell Inc
Jul 15, 2024 · The latest news at Lumicell, including events, clinical publications, regulatory updates, investors and company press releases.See details»
FDA approves Lumicell’s fluorescent system for highlighting …
Apr 19, 2024 · The FDA has granted a groundbreaking approval to a fluorescent light system that illuminates leftover breast cancer tissue in real-time during surgery—to help ensure a thorough …See details»
The Science Propelling Lumicell
The Lumicellâ„¢ Direct Visualization System (DVS) has potential utility for development in multiple solid tumor indications. Over 800 patients have been clinically evaluated in 7 different cancer …See details»
Lumicell Co-Founder Moungi Bawendi Awarded Nobel Prize in …
Oct 5, 2023 · NEWTON, Mass.-- ( BUSINESS WIRE )-- Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today …See details»
Lumicell Appoints Brent Palmisano Chief Commercial Officer, …
Jun 13, 2022 · Lumicell is a privately held company focused on innovative fluorescence-guided technologies for cancer surgery with the potential to improve patient outcomes and reduce …See details»
Lumicell Co-Founder Moungi Bawendi Awarded Nobel Prize
Oct 5, 2023 · Lumicell is a privately held company focused on improving surgical outcomes and reducing healthcare costs by utilizing its innovative fluorescence-guided surgical technologies …See details»
FDA approves Lumicell’s breast cancer visualization system
Apr 18, 2024 · Lumicell today announced it received FDA approval for its LumiSystem direct visualization system for breast cancer removal. According to the company, the LumiSystem …See details»